1. Introduction
Unnecessary gonadectomies are frequently performed in girls with benign ovarian masses (21 to 77% of cases), resulting in infertility, osteopenia, and increased cardiovascular risk. Preoperative risk stratification algorithms can reduce the incidence of unnecessary oophorectomies and prevent negative lifelong consequences [1,2].
Hypothyroidism has a significant burden of disease [3]; congenital hypothyroidism affects 1:2000 to 1/4000 newborns, but screening only covers 30% of them worldwide [4,5]. Hypothyroidism symptoms are subtle and insidious; therefore, populations at high risk, such as people with Down’s syndrome, must be screened annually to prevent severe symptoms (short stature, pericardial effusion, muscle injury, dyslipidemia, and mental retardation) [6]. Primary hypothyroidism is caused by the thyroid’s inability to secrete thyroid hormones. It leads through negative feedback to a rise in TSH hormone levels induced by the hypophysis.
Down’s syndrome affects about 12.59/10,000 to 23.71/10,000 live births [7,8]. Thyroid dysfunction in these patients is common and autoimmune mediated in the majority of cases; the optimal timing to screen for hypothyroidism is controversial, but when symptoms are evident (lethargy, anemia, short stature, and obesity), thyroid function tests are mandatory [9].
In normal circumstances, the gonads activate the follicle maturation process, including the rise in estrogen or testosterone levels and its effects (menstruation or virilization) when follicle-stimulating hormone activates its receptor. Thyroid-stimulating hormone (TSH) can activate the human FSH receptor because glycoproteins in both hormones share a common α-subunit. As a result, hypothyroidism patients may present symptoms related to FSH stimulation, including precocious puberty and ovarian cysts [10].
Van Wyk–Grumbach syndrome is a rare form of hypothyroidism. There is no information about its prevalence, but after an exhaustive search, 54 cases were found in the literature. It is the expression of gonad activation via the elevation of TSH levels. It can include peripheral precocious puberty, gonad enlargement, menstruation, virilization, and, in some cases, pituitary enlargement.
The aim of this paper is to present the case of a girl with Down’s syndrome who underwent bilateral gonadectomy due to benign cysts resulting from untreated chronic primary hypothyroidism. Additionally, we analyzed the literature related to Van Wyk–Grumbach syndrome in other patients.
2. Materials and Methods
This study was developed in two stages. The first stage is the presentation of a clinical case; the second stage consists of a review and analysis of the literature. In brief, the terms van Wyk–Grumbach syndrome, precocious puberty, ovarian cyst, children, and hypothyroidism were searched in PubMed, Imbiomed, Google Scholar, and Scopus. We included all articles that describe a Van Wyk syndrome-compatible phenotype. For each clinical case, we describe the sex, age at presentation in the hospital, age at first hypothyroidism sign, the continent of origin, comorbidities, typical hypothyroidism signs, bone age, height in cm, height in standard deviation by CDC charts, TSH concentration at diagnosis, pubertal signs, severe hypothyroidism signs, ultrasound findings, surgical treatment. SPSS V25 was used to analyze the data.
3. Results
3.1. Case Presentation
A 10-year-old female with Down’s syndrome (karyotype 47XX(20)+21), vitiligo, and a two-month history of vaginal bleeding presented to pediatric consultation with abdominal pain. An abdominopelvic ultrasound revealed an ovarian tumor of 21 cm × 8 cm.
The patient was referred to our hospital, where a second ultrasound found anechoic abdominal lesions with round, dense material inside. A subsequent CT showed two pelvic lesions of 20 HU, one of 174 cc (right ovary) and the other of 333 cc (left ovary). The left one had a round interior image of 250 HU inside. The radiological diagnosis was adnexal vs. mesenteric cystic tumors (Figure 1a,b). Blood tumor markers were negative (Table 1).
A bilateral gonadectomy and salpingectomy were performed on the patient, and the histopathological study found normal salpinges, mucinous cystadenoma, and follicular cysts of the ovaries.
Biochemical tests performed after surgery because of the patient’s Down’s syndrome condition showed severe primary hypothyroidism, LH suppression, elevated estrogen, and hyperlipidemia (Table 1). An endocrine-targeted approach to the patient revealed a history of asthenia, bone pain, progressive weight gain, dry skin one year before surgery, obesity (BMI 59.7 kg/m2), short stature (120 cm), and signs of peripheral puberty (Tanner stage 1 in breast and pubic hair and vaginal bleeding).
Finally, Van Wyk–Grumbach syndrome (severe primary hypothyroidism and isosexual peripheral precocious puberty) was diagnosed; she was treated with levothyroxine, and obesity, dry skin, asthenia, and short stature were resolved. Sexual hormone replacement started at the age of 13 years.
3.2. Literature Review
We found 54 patients reported to have Van Wyk–Grumbach syndrome [11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56], with most patients from Asia. Their main characteristics are in Table 2, Table 3, Table 4, Table 5, Table 6, Table 7 and Table 8. The age at diagnosis was from 1.5 to 24 years. All but one case [15] had typical hypothyroidism findings, and short stature was present in more than 60% of the patients. The most common symptoms that led to diagnosis were abdominal pain and vaginal bleeding. Other manifestations were severe anemia [30,31,33,36], ascites [15,31,38], ovarian torsion [16,55], intracranial mass effect [24], and Cullen’s sign [48]. Ultrasound findings included cysts in 80% of cases and complex images in 6.7%. In some cases, tumor markers were measured (31.5%), resulting in positive results in less than one-fifth of the cases (18.5%). Although thyroid substitution can reverse ovarian cysts, seven patients underwent surgery (13%) (11,24,44,51), and in one case, an oophorectomy was avoided just in time [13].
4. Discussion
Van Wyk–Grumbach syndrome is caused by peripheral gonadal stimulation mediated by elevated TSH, which results in peripheral precocious puberty. Absent negative feedback by thyroid hormones causes pituitary hyperplasia. Gonadal enlargement and vaginal bleeding in girls can lead to gonadectomy and subsequent lifetime hormonal function loss [22].
The pathophysiology of Van Wyk–Grumbach syndrome remains unclear. It is associated with variable FSH receptor sensitivity and ovarian overstimulation by elevated TSH levels. This phenomenon is seen not only in children but also in adults with recombinant TSH treatment [57,58,59]. In some cases, there are typical FSH receptors. Almost all cases had very high levels of TSH, like in this case.
In almost every case of Grumbach syndrome, classic hypothyroidism symptoms precede precocious puberty, and some symptoms may be severe or life-threatening, such as severe hypercholesterolemia, anemia, intracranial mass effect, myopathy, galactorrhea, or mental retardation. In some reports, ovarian cysts due to hypothyroidism may elevate tumor markers. In this case, short stature and progressive obesity were classical hypothyroidism symptoms. The delayed bone age found in the literature led us to think that a minimal time of TSH exposure is needed to trigger pubertal symptoms.
In all cases, treatment with levothyroxine reversed precocious puberty, ovarian cysts, tumor marker elevation, and dyslipidemia. Typical symptoms of hypothyroidism were also improved, like in this patient, with improvement in obesity and short stature.
As in this case, delayed diagnosis of hypothyroidism results in unnecessary medical visits, tests, and treatments (gonadotrophin tests for precocious puberty, invasive tests for short stature, and surgery). We believe that many cases like ours have not been published [60,61].
Hypothyroidism diagnosis can be a challenge; non-diagnosed congenital hypothyroidism has a 4-year delay in diagnosis even with typical symptoms [62]. It is not unusual to find patients with hypothyroidism with atypical manifestations that have emerged because of a long-standing disease [63]. In particular, growth restriction is found in hypothyroidism, as in our case in 63% of VWG syndrome cases reported in the literature. This is accompanied by a severely delayed bone age, which we believe is directly related to hypothyroidism evolution time [64]. In this case, the evaluation of an endocrinologist after surgery was needed to diagnose the condition, evading the suspicion of the pediatric emergency team and the surgical service.
About 11% of patients with Van Wyk–Grumbach syndrome have Down’s syndrome. Persons living with Down’s syndrome must be screened for thyroid disorders annually, before any surgery or when another autoimmune disease appears. Approximately 50% will develop some form of thyroid dysfunction in their lives (hypothyroidism 39%, congenital hypothyroidism 7%, and hyperthyroidism 3%) [65,66]. The patient presented in this case did not have this annual evaluation, nor was it performed before surgery. This group of patients needs a very diligent pediatric team to prevent this outcome.
Irreversible treatment decisions in children, such as gonadectomy, must be based on reliable tools to avoid overtreatment and its long-term consequences [2].
Children with peripheral precocious puberty and gonadal masses must be studied for hypothyroidism before any radical decision is made, and complete clinical and metabolic evaluation is warranted in the search for other consequences of long-standing hypothyroidism.
Conceptualization, A.A.A.-L. and A.H.-C.; methodology, A.A.A.-L. and A.H.-C.; software, A.A.A.-L. and A.H.-C.; validation, E.D.-M. and M.A.C.-R.; formal analysis, A.A.A.-L.; investigation, E.D.-M. and M.A.C.-R.; resources, A.A.A.-L.; data curation, A.A.A.-L.; writing—original draft preparation, A.A.A.-L.; writing—review and editing, A.H.-C.; visualization, A.H.-C.; supervision, A.H.-C.; project administration, A.H.-C.; funding acquisition, A.H.-C. All authors have read and agreed to the published version of the manuscript.
The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Instituto Mexicano del Seguro Social 7 March 2024 (R-2024-3504-023).
Written informed consent was obtained from the patient to publish this paper.
Data are contained within the article.
We acknowledge Instituto Mexicano del Seguro Social for its support.
The authors declare no conflicts of interest.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Figure 1. (a) Tomography image of the two pelvic tumors, A: Anterior; (b) ultrasound image of a pelvic tumor, T: Transductor.
Initial laboratory findings in this case.
Laboratory | Result | Normal Range |
---|---|---|
Alpha-fetoprotein | 4.86 ng/mL | 0 to 7 ng/mL |
Carcinoembryonic antigen | 3.84 ng/mL | 0 to 3.8 ng/mL |
Chorionic gonadotropin | <0.10 | non detectable |
CA-125 | 25.39 UI/mL | 0 to 35 UI/mL |
TSH | 367.3 μUI/mL | 0.27 to 4.2 μUI/mL |
Total T4 | 0.49 μg/dL | 5.1 a 14.1 μg/dL |
Free T4 | 0.06 ng/dL | 0.93 to 1.7 ng/dL |
Total T3 | <0.20 ng/mL | 0.8 to 2 ng/mL |
Free T3 | 1.59 pmol/L | 1.73 to 6.3 pmol/L |
Anti-thyroglobulin | 150.5 ng/dL | 5 to 100 |
LH | <0.10 mUI/mL | <0.10 mUI/mL |
Estradiol | 63.53 pg/mL | Non detectable |
FSH | 5.19 mUI/mL | 0 to 5 mUI/mL |
Total cholesterol | 305 mg/dL | 120 to 200 mg/dL |
Triglycerides | 332 mg/dL | 35 to 135 mg/dL |
Main characteristics of reports of Van Wyk–Grumbach syndrome.
Variable | Result n (%) or * Median (Interquartile Range) |
---|---|
Place of report | |
Asia | 29 (53.7) |
America | 18 (33.3) |
Europe | 7 (13) |
Female sex | 51(94) |
Age at diagnosis, years | 9.95 (7.37 to 14) * |
Comorbidities | 9 (16.6) |
Down’s syndrome | 6 (11.1) |
Alport syndrome | 1(1.9) |
Hemangioma | 1 (1.9) |
Typical hypothyroidism findings at presentation.
Variable | n (%) from All Studies or * Median (Interquartile Range) | Percentage of Studies That Report the Symptom |
---|---|---|
Mental retardation | 12 (22.2) | 13 (24.1) |
Edema/myxedema | 18 (33.3) | 19 (35.2) |
Dry skin | 22 (37) | 22 (37) |
Puffy face | 19 (33.3) | 19 (33.3) |
Hypoactivity or asthenia | 23 (38.9) | 23 (38.9) |
Constipation | 13 (24.1) | 14 (24.1) |
Bradycardia | 8 (14.8) | 8 (14.8) |
Anemia | 27 (46.3) | 25 (48.1) |
Hb g/dL | 9 (7.9 to 10) * | |
Alopecia | 1 (1.9) | 1 (1.9) |
Irregular menstrual rhythm | 6 (11.1) | 6 (11.1) |
Myopathy or muscular weakness | 6 (11.1) | 6 (11.1) |
Short stature | 34 (63) | 39 (72) |
Height (CDC sz) | −3.47 (−2.45 to −4.76) * | |
Obesity | 15 (27.8) | 17 (31.5) |
Hypercholesterolemia | 7 (13) | 7 (13) |
Total cholesterol mg/dL | 345 (299 to 444) * | |
Delayed bone age | 31 (57.4) | 36 (64.7) |
Bone age delay, years | −3 (−4 to −1.5) * | |
Number of findings | ||
0 | 1 (1.9) | |
1 to 5 | 35 (64.6) | |
6 to 10 | 18 (33.5) | |
Time from typical hypothyroidism findings to diagnosis, years | 2 (1 to 5) | |
TSH mUI/mL | 490 (100 to 939) * | 35 (63.3) |
TSH > 100 | 42 (77.8) | |
TSH < 100 | 10 (18.5) |
CDC: Central Disease Center.
Symptoms that led to medical consultation.
Symptom | n (%) |
---|---|
Vaginal bleeding | 23 (42.3) |
Abdominal pain | 15 (27.8) |
Abdominal bloating | 3 (5.6) |
Abnormal menstruation (irregularity or metrorrhagia) | 4 (7.4) |
Other (ascites, headache, clitoromegaly, Cullen’s sign, abdominal mass, precocious puberty, short stature, and muscular weakness) | 9 (16.6) |
Puberal or gonadal-related findings of hypothyroidism at diagnosis.
Symptom | n (%) |
---|---|
Puberal or sexual symptom | |
Vaginal bleeding | 33 (61.1) |
Macroorchidism | 3 (5.6) |
Clitoromegaly | 2 (3.7) |
Puberal delay | 1 (1.9) |
Severe findings of hypothyroidism at diagnosis.
Symptom | n (%) |
---|---|
Anemia requiring transfusion | 2 (3.8) |
Ascites | 4 (7.4) |
Pericardial effusion | 5 (9.2) |
Intracranial mass effect | 1 (1.9) |
Cullen’s sign | 1 (1.9) |
Ovarian torsion | 3 (5.5) |
Pituitary hyperplasia | 18 (33.3) |
Hyperprolactinemia | 29 (53.7) |
Elevated AST | 1 (1.9) |
Gonadal ultrasound findings at diagnosis.
Findings | n (%) |
---|---|
Multiple cysts | 23 (51.1) |
Cysts | 13 (28.9) |
Ovarian enlargement | 5 (11.1) |
Ovarian tumor or complex images | 3 (6.7) |
Other | 1 (2.2) |
Surgery indications.
Type of Surgery | n (%) |
---|---|
Cystectomy | 2 (28.5) |
Ovary detorsion | 2 (28.5) |
Ovary biopsy | 1 (14.2) |
Bilateral oophorectomy | 1 (14.2) |
Aborted oophorectomy | 1 (14.2) |
References
1. Gonzalez, D.O.; Cooper, J.N.; Aldrink, J.H.; Hewitt, G.D.; Fallat, M.E.; Minneci, P.C.; Deans, K.J. Variability in Surgical Management of Benign Ovarian Neoplasms in Children. J. Pediatr. Surg.; 2017; 52, pp. 944-950. [DOI: https://dx.doi.org/10.1016/j.jpedsurg.2017.03.014] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28343661]
2. Minneci, P.C.; Bergus, K.C.; Lutz, C.; Aldrink, J.; Bence, C.; Breech, L.; Dillon, P.A.; Downard, C.; Ehrlich, P.F.; Fallat, M. et al. Reducing Unnecessary Oophorectomies for Benign Ovarian Neoplasms in Pediatric Patients. JAMA; 2023; 330, pp. 1247-1254. [DOI: https://dx.doi.org/10.1001/jama.2023.17183] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37787794]
3. Hepp, Z.; Lage, M.J.; Espaillat, R.; Gossain, V.V. The Direct and Indirect Economic Burden of Hypothyroidism in the United States: A Retrospective Claims Database Study. J. Med. Econ.; 2021; 24, pp. 440-446. [DOI: https://dx.doi.org/10.1080/13696998.2021.1900202] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33685322]
4. Rendón-Macías, M.E.; Morales-García, I.; Huerta-Hernández, E.; Silva-Batalla, A.; Villasís-Keever, M.A. Birth Prevalence of Congenital Hypothyroidism in Mexico. Paediatr. Perinat. Epidemiol.; 2008; 22, pp. 478-485. [DOI: https://dx.doi.org/10.1111/j.1365-3016.2008.00955.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18782254]
5. Ford, G.; LaFranchi, S.H. Screening for Congenital Hypothyroidism: A Worldwide View of Strategies. Best Pract. Res. Clin. Endocrinol. Metab.; 2014; 28, pp. 175-187. [DOI: https://dx.doi.org/10.1016/j.beem.2013.05.008] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24629860]
6. Feldt-Rasmussen, U.; Effraimidis, G.; Bliddal, S.; Klose, M. Risks of Suboptimal and Excessive Thyroid Hormone Replacement across Ages. J. Endocrinol. Investig.; 2023; 47, pp. 1083-1090. [DOI: https://dx.doi.org/10.1007/s40618-023-02229-7]
7. Forrester, M.B.; Merz, R.D. Epidemiology of Down Syndrome (Trisomy 21), Hawaii, 1986–1997. Teratology; 2002; 65, pp. 207-212. [DOI: https://dx.doi.org/10.1002/tera.10042] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11967919]
8. Martini, J.; Bidondo, M.P.; Duarte, S.; Liascovich, R.; Barbero, P.; Groisman, B. Birth Prevalence of Down Syndrome in Argentina. Salud Colect.; 2019; 15, e1863. [DOI: https://dx.doi.org/10.18294/sc.2019.1863]
9. Graber, E.; Chacko, E.; Regelmann, M.O.; Costin, G.; Rapaport, R. Down Syndrome and Thyroid Function. Endocrinol. Metab. Clin. N. Am.; 2012; 41, pp. 735-745. [DOI: https://dx.doi.org/10.1016/j.ecl.2012.08.008]
10. Pierce, J.G.; Parsons, T.F. Glycoprotein Hormones: Structure and Function. Annu. Rev. Biochem.; 1981; 50, pp. 465-495. [DOI: https://dx.doi.org/10.1146/annurev.bi.50.070181.002341]
11. Baranowski, E.; Högler, W. An Unusual Presentation of Acquired Hypothyroidism: The Van Wyk-Grumbach Syndrome. Eur. J. Endocrinol.; 2012; 166, pp. 537-542. [DOI: https://dx.doi.org/10.1530/EJE-11-0494]
12. Barbero, A.; Pagano, M.; Tuli, G.; Buganza, R.; de Sanctis, L.; Bondone, C. Menorrhagia as Main Presentation Sign of Severe Hypothyroidism in a Pediatric Patient: A Case Report. Ital. J. Pediatr.; 2022; 48, 171. [DOI: https://dx.doi.org/10.1186/s13052-022-01363-x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36089580]
13. Bhagwat, N.M.; Dalwadi, P.P.; Joshi, A.S.; Pawal, P.S.; Varthakavi, P.K. Asymmetrical Ovarian Enlargement: Caught Timely Before the Cut!. J. Pediatr. Adolesc. Gynecol.; 2015; 28, pp. e83-e85. [DOI: https://dx.doi.org/10.1016/j.jpag.2014.07.004] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25817767]
14. Biswas, M.; Sinha, M.K.; Das, M.K.; Sarkar, S. Van Wyk-Grumbach Syndrome with Hemangioma in an Infant. J. Pediatr. Endocrinol. Metab. JPEM; 2018; 31, pp. 1057-1060. [DOI: https://dx.doi.org/10.1515/jpem-2018-0049]
15. Browne, L.P.; Boswell, H.B.; Crotty, E.J.; O’Hara, S.M.; Birkemeier, K.L.; Guillerman, R.P. Van Wyk and Grumbach Syndrome Revisited: Imaging and Clinical Findings in Pre- and Postpubertal Girls. Pediatr. Radiol.; 2008; 38, pp. 538-542. [DOI: https://dx.doi.org/10.1007/s00247-008-0777-1] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18283448]
16. Burns, L.P.; Pennesi, C.M.; Rosen, M.W.; Araya, A.; Baruch, A.; Arnold, M.A.; Quint, E.H. Interdisciplinary Care and a Focus on Fertility Preservation When Multi-Cystic Ovaries Cause Ovarian Torsion: A Case of a 9-Year-Old Girl with Severe, Undiagnosed Hypothyroidism. J. Pediatr. Adolesc. Gynecol.; 2020; 33, pp. 723-726. [DOI: https://dx.doi.org/10.1016/j.jpag.2020.09.002] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32977007]
17. Campaner, A.B.; Scapinelli, A.; Machado, R.O.; Dos Santos, R.E.; Beznos, G.W.; Aoki, T. Primary Hypothyroidism Presenting as Ovarian Tumor and Precocious Puberty in a Prepubertal Girl. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol.; 2006; 22, pp. 395-398. [DOI: https://dx.doi.org/10.1080/09513590600819032]
18. Chattopadhyay, A.; Kumar, V.; Marulaiah, M. Polycystic Ovaries, Precocious Puberty and Acquired Hypothyroidism: The Van Wyk and Grumbach Syndrome. J. Pediatr. Surg.; 2003; 38, pp. 1390-1392. [DOI: https://dx.doi.org/10.1016/S0022-3468(03)00403-2] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14523827]
19. Chemaitilly, W.; Trivin, C.; Adan, L.; Gall, V.; Sainte-Rose, C.; Brauner, R. Central Precocious Puberty: Clinical and Laboratory Features. Clin. Endocrinol.; 2001; 54, pp. 289-294. [DOI: https://dx.doi.org/10.1046/j.1365-2265.2001.01229.x]
20. Christens, A.; Sevenants, L.; Toelen, J.; Bullens, D.; Casteels, K. Van Wyk and Grumbach Syndrome: An Unusual Form of Precocious Puberty. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol.; 2014; 30, pp. 272-276. [DOI: https://dx.doi.org/10.3109/09513590.2013.871523] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24568556]
21. Durbin, K.L.; Diaz-Montes, T.; Loveless, M.B. Van Wyk and Grumbach Syndrome: An Unusual Case and Review of the Literature. J. Pediatr. Adolesc. Gynecol.; 2011; 24, pp. e93-e96. [DOI: https://dx.doi.org/10.1016/j.jpag.2010.08.003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21600802]
22. Egodawaththe, N.S.; Seneviratne, S.N.; Gunasekara, S.; Amarasekara, S.M.; Weerasekara, K. Van Wyk-Grumbach Syndrome and Oligosyndactyly in a 6-Year-Old Girl: A Case Report. J. Med. Case Rep.; 2020; 14, 166. [DOI: https://dx.doi.org/10.1186/s13256-020-02472-z] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32933589]
23. Esen, I.; Demirel, F. Hypothyroidism-Associated Testicular Enlargement: Is It a Form of Precocious Puberty or Not? A Case Report. Turk. J. Pediatr.; 2011; 53, pp. 210-212. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21853662]
24. Guerrero, N.; Athanassaki, I.D.; Sebastian, M.R. Prolonged Untreated Disease and Limited English Proficiency: A Case of Van Wyk-Grumbach Syndrome. J. Adolesc. Health Off. Publ. Soc. Adolesc. Med.; 2021; 69, pp. 171-174. [DOI: https://dx.doi.org/10.1016/j.jadohealth.2020.10.016] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33221188]
25. Gordon, C.M.; Austin, D.J.; Radovick, S.; Laufer, M.R. Primary Hypothyroidism Presenting as Severe Vaginal Bleeding in a Prepubertal Girl. J. Pediatr. Adolesc. Gynecol.; 1997; 10, pp. 35-38. [DOI: https://dx.doi.org/10.1016/S1083-3188(97)70042-1]
26. Lee, S.-J.; Moon, J.-E.; Lee, G.-M.; Cho, M.-H.; Ko, C.W. An Alport Syndrome Boy with Van Wyk-Grumbach Syndrome Induced by Prolonged Untreated Congenital Hypothyroidism. Ann. Pediatr. Endocrinol. Metab.; 2020; 25, pp. 132-136. [DOI: https://dx.doi.org/10.6065/apem.1938074.037] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32615694]
27. Gupta, J.; Lin-Su, K. Van Wyk-Grumbach Syndrome in a Female Pediatric Patient with Trisomy 21: A Case Report. Int. J. Pediatr. Endocrinol.; 2020; 2020, 2. [DOI: https://dx.doi.org/10.1186/s13633-020-0072-y] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32002020]
28. Hansen, K.A.; Tho, S.P.; Hanly, M.; Moretuzzo, R.W.; McDonough, P.G. Massive Ovarian Enlargement in Primary Hypothyroidism. Fertil. Steril.; 1997; 67, pp. 169-171. [DOI: https://dx.doi.org/10.1016/S0015-0282(97)81876-6] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8986704]
29. Hunold, A.; Alzen, G.; Wudy, S.A.; Bluetters-Sawatzki, R.; Landmann, E.; Reiter, A.; Wagner, H.-J. Ovarian Tumor in a 12-Year Old Female with Severe Hypothyroidism: A Case of Van Wyk and Grumbach Syndrome. Pediatr. Blood Cancer; 2009; 52, pp. 677-679. [DOI: https://dx.doi.org/10.1002/pbc.21920]
30. Indumathi, C.K.; Bantwal, G.; Patil, M. Primary Hypothyroidism with Precocious Puberty and Bilateral Cystic Ovaries. Indian J. Pediatr.; 2007; 74, pp. 781-783. [DOI: https://dx.doi.org/10.1007/s12098-007-0140-9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17785906]
31. Krishnamurthy, S.; Seth, A.; Puri, A.; Anand, R.; Aneja, S. Ovarian Tumors with Elevated CA-125 Levels and Severe Juvenile Hypothyroidism: A Need for Increased Awareness. Indian J. Pediatr.; 2010; 77, pp. 693-694. [DOI: https://dx.doi.org/10.1007/s12098-010-0081-6] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20532693]
32. Kubota, K.; Itho, M.; Kishi, H.; Igarashi, S.; Minegishi, T. Primary Hypothyroidism Presenting as Multiple Ovarian Cysts in an Adult Woman: A Case Report. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol.; 2008; 24, pp. 586-589. [DOI: https://dx.doi.org/10.1080/09513590802288192]
33. Kumar, S.; Mahesh, D.M.; Vignesh, G.; Sagili, H.; Dhanapathi, H.; Hamide, A. Congenital Hypothyroidism Presenting as Menorrhagia in Adulthood. J. Assoc. Physicians India; 2013; 61, pp. 660-661. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24772707]
34. Leonardi, A.; Penta, L.; Cofini, M.; Lanciotti, L.; Principi, N.; Esposito, S. Rhabdomyolysis in a Young Girl with Van Wyk-Grumbach Syndrome Due to Severe Hashimoto Thyroiditis. Int. J. Environ. Res. Public Health; 2018; 15, 704. [DOI: https://dx.doi.org/10.3390/ijerph15040704] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29642533]
35. Lim, H.H.; Kil, H.R.; Kim, J.Y. Unusual Presentations of a Girl with Down Syndrome: Van Wyk-Grumbach Syndrome. J. Pediatr. Endocrinol. Metab. JPEM; 2012; 25, pp. 1209-1212. [DOI: https://dx.doi.org/10.1515/jpem-2012-0195]
36. Marr, A.; Hardy, K.; Curtis, J. A 14-Year-Old Girl with Short Stature, Incomplete Puberty and Severe Menstrual Bleeding. Paediatr. Child Health; 2018; 23, pp. 85-88. [DOI: https://dx.doi.org/10.1093/pch/pxx113] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29686489]
37. Moreno-Guzmán, L.; Sandoval-Benítez, M.; Núñez-Hernández, J.; Sánchez-Castillo, J. Virilización Secundaria a Hiperandrogenismo Ovárico En Síndrome de Van Wyk-Grumbach: Reporte de Un Caso. Arch. Investig. Mater. Inf.; 2015; 7, pp. 104-106.
38. Motamed, F.; Eftekhari, K.; Kiani, M.A.; Rabbani, A. Ovarian Cyst Enlargement in a 14 Year Old Female with Persistent Ascities, Severe Hypothyroidism and Elevated Serum CA-125 Level. Iran. Red Crescent Med. J.; 2012; 14, pp. 379-381.
39. Oden Akman, A.; Tayfun, M.; Demirel, F.; Ucakturk, S.A.; Gungor, A. Association of Van Wyk Grumbach and Debre Semelaigne Syndromes with Severe Hypothyroidism. J. Pediatr. Adolesc. Gynecol.; 2015; 28, pp. e161-e163. [DOI: https://dx.doi.org/10.1016/j.jpag.2015.03.004] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26165912]
40. Patni, N.; Cervantes, L.F.; Diaz, A. Elevated Alpha-Fetoprotein Levels in Van Wyk-Grumbach Syndrome: A Case Report and Review of Literature. J. Pediatr. Endocrinol. Metab. JPEM; 2012; 25, pp. 761-767. [DOI: https://dx.doi.org/10.1515/jpem-2012-0112] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23155707]
41. Rastogi, A.; Bhadada, S.K.; Bhansali, A. An Unusual Presentation of a Usual Disorder: Van Wyk-Grumbach Syndrome. Indian J. Endocrinol. Metab.; 2011; 15, pp. S141-S143. [DOI: https://dx.doi.org/10.4103/2230-8210.83356] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21966653]
42. Reddy, P.; Tiwari, K.; Kulkarni, A.; Parikh, K.; Khubchandani, R. Van Wyk Grumbach Syndrome: A Rare Consequence of Hypothyroidism. Indian J. Pediatr.; 2018; 85, pp. 1028-1030. [DOI: https://dx.doi.org/10.1007/s12098-018-2704-2] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29777468]
43. Rivera-Hernández, A.; Madrigal-González, M.M.; Espinosa-Peniche, R.; Zurita-Cruz, J.; Balcázar-Hernández, L. Van Wyk-Grumbach Syndrome and Trisomy 21. Proc. Bayl. Univ. Med. Cent.; 2022; 35, pp. 569-571. [DOI: https://dx.doi.org/10.1080/08998280.2022.2054048]
44. Sherwani, P.; Nandolia, K.K.; Joshi, K.; Lourembam, R. Imaging in Van Wyk Grumbach Syndrome: An Uncommon Presentation of Hypothyroidism. SA J. Radiol.; 2023; 27, 2572. [DOI: https://dx.doi.org/10.4102/sajr.v27i1.2572] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37065974]
45. Shivaprasad, K.S.; Dutta, D.; Jain, R.; Kumar, M.; Maisnam, I.; Biswas, D.; Ghosh, S.; Mukhopadhyay, S.; Chowdhury, S. Huge Bilateral Ovarian Cysts in Adulthood as the Presenting Feature of Van Wyk Grumbach Syndrome Due to Chronic Uncontrolled Juvenile Hypothyroidism. Indian J. Endocrinol. Metab.; 2013; 17, pp. S164-S166. [DOI: https://dx.doi.org/10.4103/2230-8210.119559] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24251145]
46. Singh, B.M.; Ammini, A.C.; Kriplani, A. Ovarian Cyst in Juvenile Hypothyroidism. Arch. Gynecol. Obstet.; 2005; 271, pp. 262-263. [DOI: https://dx.doi.org/10.1007/s00404-003-0581-y] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15243754]
47. Sneha, L.M.; Thanasegarapandian, K.; Paramasivam, V.; Scott, J.X. Short Stature and an Interesting Association. Indian J. Hum. Genet.; 2013; 19, pp. 101-103. [DOI: https://dx.doi.org/10.4103/0971-6866.112919] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23901203]
48. Sultan, A.; Velaga, M.R.; Fleet, M.; Cheetham, T. Cullen’s Sign and Massive Ovarian Enlargement Secondary to Primary Hypothyroidism in a Patient with a Normal FSH Receptor. Arch. Dis. Child.; 2006; 91, pp. 509-510. [DOI: https://dx.doi.org/10.1136/adc.2005.088443]
49. Takeuchi, K.; Deguchi, M.; Takeshima, Y.; Maruo, T. A Case of Multiple Ovarian Cysts in a Prepubertal Girl with Severe Hypothyroidism Due to Autoimmune Thyroiditis. Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc.; 2004; 14, pp. 543-545. [DOI: https://dx.doi.org/10.1136/ijgc-00009577-200405000-00019]
50. Ozgen, T.; Güven, A.; Aydin, M. Precocious Puberty in a Girl with Down Syndrome Due to Primary Hypothyroidism. Turk. J. Pediatr.; 2009; 51, pp. 381-383. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19950849]
51. Tran, S.; Kim, E.E.; Chin, A.C. Severe Menorrhagia, Unilateral Ovarian Mass, Elevated Inhibin Levels, and Severe Hypothyroidism: An Unusual Presentation of Van Wyk and Grumbach Syndrome. J. Pediatr. Surg.; 2013; 48, pp. e51-e54. [DOI: https://dx.doi.org/10.1016/j.jpedsurg.2012.10.064]
52. Waddankeri, S.; Waddankeri, M.; Waddankeri, S.; Arora, K. The Clinical Septet of Van Wyk-Grumbach Syndrome: A Case Series from a Tertiary Care Centre in Kalyana Karnataka, India. Touchrev. Endocrinol.; 2023; 19, pp. 98-102. [DOI: https://dx.doi.org/10.17925/EE.2023.19.1.98] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37313241]
53. Iqbal, M.Z.; Saleem, M.; Shahzad, Z.A. A Case of van Wyk-Grumbach Syndrome. APSP J. Case Rep.; 2013; 4, 24. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24040602]
54. Zhang, S.; Yang, J.; Zheng, R.; Jiang, L.; Wei, Y.; Liu, G. VanWyk-Grumbach Syndrome in a Male Pediatric Patient: A Rare Case Report and Literature Review. Exp. Ther. Med.; 2017; 13, pp. 1151-1154. [DOI: https://dx.doi.org/10.3892/etm.2017.4086] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28450956]
55. Zhang, H.; Geng, N.; Wang, Y.; Tian, W.; Xue, F. Van Wyk and Grumbach Syndrome: Two Case Reports and Review of the Published Work. J. Obstet. Gynaecol. Res.; 2014; 40, pp. 607-610. [DOI: https://dx.doi.org/10.1111/jog.12181] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24118179]
56. Zhu, W.; Yang, Y.; Zhao, Y.; Tang, H.; Zhang, X.; Shi, R.; Zhao, Y.; Han, R. Primary Juvenile Hypothyroidism Concurrent with Huge Bilateral Cystic Ovaries: Case Report and Literature Review. Arch. Pediatr. Organe Off. Soc. Fr. Pediatr.; 2021; 28, pp. 96-100. [DOI: https://dx.doi.org/10.1016/j.arcped.2020.10.016] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33339721]
57. Vasseur, C.; Rodien, P.; Beau, I.; Desroches, A.; Gérard, C.; de Poncheville, L.; Chaplot, S.; Savagner, F.; Croué, A.; Mathieu, E. et al. A Chorionic Gonadotropin-Sensitive Mutation in the Follicle-Stimulating Hormone Receptor as a Cause of Familial Gestational Spontaneous Ovarian Hyperstimulation Syndrome. N. Engl. J. Med.; 2003; 349, pp. 753-759. [DOI: https://dx.doi.org/10.1056/NEJMoa030065] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12930927]
58. Smits, G.; Olatunbosun, O.; Delbaere, A.; Pierson, R.; Vassart, G.; Costagliola, S. Ovarian Hyperstimulation Syndrome Due to a Mutation in the Follicle-Stimulating Hormone Receptor. N. Engl. J. Med.; 2003; 349, pp. 760-766. [DOI: https://dx.doi.org/10.1056/NEJMoa030064]
59. Rizvi, T.; Rehm, P.K. Recombinant Human Thyrotropin Use Resulting in Ovarian Hyperstimulation: An Unusual Side Effect. Eur. Thyroid J.; 2014; 3, pp. 125-129. [DOI: https://dx.doi.org/10.1159/000360852] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25114876]
60. Easterbrook, P.J.; Berlin, J.A.; Gopalan, R.; Matthews, D.R. Publication Bias in Clinical Research. Lancet; 1991; 337, pp. 867-872. [DOI: https://dx.doi.org/10.1016/0140-6736(91)90201-Y] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1672966]
61. Nair, A.S. Publication Bias-Importance of Studies with Negative Results!. Indian J. Anaesth.; 2019; 63, pp. 505-507. [DOI: https://dx.doi.org/10.4103/ija.IJA_142_19]
62. Seth, A.; Aggarwal, V.; Maheshwari, A. Hypothyroidism in Children beyond 5 y of Age: Delayed Diagnosis of Congenital Hypothyroidism. Indian J. Pediatr.; 2012; 79, pp. 891-895. [DOI: https://dx.doi.org/10.1007/s12098-011-0678-4] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22237638]
63. Khera, S.; Venkateshwar, V.; Kanitkar, M.; Devgan, A. Varied Presentations of Hypothyroidism in Children. Med. J. Armed Forces India; 2011; 67, pp. 174-176. [DOI: https://dx.doi.org/10.1016/S0377-1237(11)60028-2]
64. Gutch, M.; Philip, R.; Philip, R.; Toms, A.; Saran, S.; Gupta, K.K. Skeletal Manifestations of Juvenile Hypothyroidism and the Impact of Treatment on Skeletal System. Indian J. Endocrinol. Metab.; 2013; 17, pp. S181-S183. [DOI: https://dx.doi.org/10.4103/2230-8210.119565] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24251152]
65. Bull, M.J.; Trotter, T.; Santoro, S.L.; Christensen, C.; Grout, R.W. Council on Genetics Burke, L.W.; Berry, S.A.; Geleske, T.A.; Holm, I. et al. Health Supervision for Children and Adolescents with Down Syndrome. Pediatrics; 2022; 149, e2022057010. [DOI: https://dx.doi.org/10.1542/peds.2022-057010]
66. Rodriguez, L.; Dinauer, C.; Francis, G. Treatment of Hypothyroidism in Infants, Children and Adolescents. Trends Endocrinol. Metab. TEM; 2022; 33, pp. 522-532. [DOI: https://dx.doi.org/10.1016/j.tem.2022.04.007] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35537910]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Van Wyk–Grumbach syndrome (VWGS) refers to the development of peripheral precocious puberty, long-standing hypothyroidism, and gonadal masses; when not diagnosed, an unnecessary gonadectomy may be performed. Herein, we present a case of a 10-year-old girl with Down’s syndrome, short stature, and vitiligo who presented to our hospital with vaginal bleeding and a palpable pelvic mass. Upon ultrasound and topographical examination, bilateral ovarian masses with negative tumor markers were detected. After bilateral gonadectomy, endocrine studies revealed profound hypothyroidism and peripheral puberty that led to the VWGS syndrome diagnosis (TSH 367.3 mUI/mL, isolated menstruation, indetectable LH, and elevated estradiol). Levothyroxine treatment improved obesity and short stature, and sexual hormone replacement began at 13 years of age. The literature on Van Wyk–Grumbach syndrome shows that it presents most often in women, and classic hypothyroidism symptoms always precede the diagnosis. Approximately 11% of patients have Down’s syndrome, sometimes tumor markers are elevated, and some develop severe symptoms (myopathy, short stature, mental delay, ascites, pericardial effusion, Cullen’s sign, pituitary hyperplasia, and severe anemia) that respond to levothyroxine treatment. Conclusions: Children with peripheral precocious puberty and gonadal masses must be studied for hypothyroidism before any radical decision is made.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Instituto Mexicano del Seguro Social, UMAE Hospital de Gineco Obstetricia No. 3 La Raza, Mexico City 02990, Mexico
2 Instituto Mexicano del Seguro Social, División de Evaluación de Tecnologías en Salud, Mexico City 02990, Mexico;
3 Instituto Mexicano del Seguro Social, UMAE Hospital General La Raza, Mexico City 02990, Mexico;